You are here » Home » Companies » Company Overview » Nutraplus India Ltd

Nutraplus India Ltd.

BSE: 524764 Sector: Health care
NSE: N.A. ISIN Code: INE230G01020
BSE LIVE 12:10 | 17 Aug 28.55 0
(0.00%)
OPEN

29.80

HIGH

29.80

LOW

27.15

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 29.80
PREVIOUS CLOSE 28.55
VOLUME 18159
52-Week high 43.50
52-Week low 19.60
P/E
Mkt Cap.(Rs cr) 97
Buy Price 28.50
Buy Qty 874.00
Sell Price 28.55
Sell Qty 814.00
OPEN 29.80
CLOSE 28.55
VOLUME 18159
52-Week high 43.50
52-Week low 19.60
P/E
Mkt Cap.(Rs cr) 97
Buy Price 28.50
Buy Qty 874.00
Sell Price 28.55
Sell Qty 814.00

Nutraplus India Ltd. (NUTRAPLUSINDIA) - Company History

Nutraplus Products (India) Limited was originally incorporated as a private limited company on 6 Feb.'90. It was subsequently converted into a public limited company with effect from 13 Jun.'92. The company implemented a project for the manufacture of veterinary bulk drugs namely dimentridazole (DMZ) and dinitolmide (DOT) at Tarapur, Maharashtra. Initially, the company set up manufacturing facilities for the manufacture of methyl nitro imidazole, an intermediate of DMZ, with an installed capacity of 240 tpa, at a cost of Rs 123.66 lac, for which was sanctioned a term loan of Rs 60 lac from the Maharashtra State Financial Corporation (MSFC). The company has set-up new product Roxarsone from Jan'96 and also set up production of Dinitolmide. During 2001-02 the company set up a production of newly developed Bulk Drugs Metformin HCL. It is also planning to foray in the manufacture of life saving drugs.